GNNSF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genscript Biotech Corp

Watchlist Manager

Watchlist

Price: 1.5 USD Market Closed

Market Cap: $3.2B

G	Genscript Biotech Corp OTC:GNNSF	CN
H	Hudson Technologies Inc F:HT4	US
G	Grupa Azoty SA XBER:5PL	PL
	Aallon Group Oyj F:I74	FI
	Grupa Azoty SA F:5PL	PL
A	Asta Co Ltd KOSDAQ:246720	KR

Profitability Summary

Genscript Biotech Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Sustainable 3Y Average Gross Margin

49%

Gross Margin is Increasing

43% > 58%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

-64% > 27%

Negative Net Margin

-56%

Strong 3Y Average Net Margin

154%

Declining Net Margin

-27% > -56%

Exceptional Free Cash Flow Margin

15%

Negative 3Y Average Free Cash Flow Margin

-26%

Free Cash Flow Margin is Increasing

-63% > 15%

Negative ROE

-13%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.